Bracco Innovations Featured at RSNA 2024 Explore the advanced diagnostic imaging solutions Bracco presented at RSNA 2024, including contrast agents, injectors, and AI-driven tools.

Bracco triples production of its innovative ultrasound contrast agent in Geneva Over 80 million euros has been invested to build Hexagon, a new manufacturing facility located next to the historical 1996 plant which will, when fully operational, triple the production and distribution of one of the leading products from Bracco's research.

EuSoMII and Bracco together for the 2nd AI Contest One year is gone and we are back in Pisa. It’s the 10th (and 11th) of October 2024, and the EuSoMII, is hosting its annual meeting that brings together people with different backgrounds and expertise from the world of radiology. 

ColoWatch® and Bracco Diagnostics Partner to Expand the Availability of Virtual Colonoscopy for the Early Detection of Colon and Rectal Cancer To learn more, visit Bracco’s booth #3300 at the Radiological Society of North America (RSNA) 2024 Annual Meeting, to be held from December 1-5 in Chicago, Illinois

Webinar: Effective Gadolinium Reduction with the New High- Relaxivity Gadopiclenol in CNS We are pleased to invite you to join an educational webinar entitled Effective Gadolinium Reduction with the New High- Relaxivity Gadopiclenol in CNS scheduled for January 15 from 6:00 to 7:00 pm CET.

Bracco Launches VARIBAR® Barium Sulfate MINIS Bracco Diagnostics expands its VARIBAR® product line with barium sulfate MINIS for improved diagnostic swallow studies and patient compliance.

Bracco and Aenitis Partner on Acoustic Beads for Cell Sorting This strategic partnership is set to explore the development of next-generation acoustic microspheres, a groundbreaking alternative to conventional magnetic beads for rare and complex cell sorting and separation in flow-based applications.

Contact Bracco: Get Support and Information Contact Bracco for product inquiries, technical support, or general questions regarding our imaging solutions and services worldwide.

Bracco Imaging Receives FDA Fast Track Designation for BR55 Bracco Imaging announced today that the U.S. FDA has granted Fast Track designation for the development of BR55 (perfluorobutane/nitrogen lipopeptide-coated microbubbles) injection for detecting areas of active bowel inflammation in patients with Crohn's disease.

PGP key